Home › Funds › Nan Fung Group Holdings Ltd › HRMY

Nan Fung Group Holdings Ltd position in HRMY

HARMONY BIOSCIENCES HLDGS IN · Health Care

Nan Fung Group Holdings Ltd reported holding 27,049 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.72% of its reported portfolio and ranking #21 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed HRMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)27.05K sh
Reported value held$1.06M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nan Fung Group Holdings Ltd's HRMY position evolved

Nan Fung Group Holdings Ltd first disclosed a stake in HRMY in Q3 2023 at 368,665 shares (US$12.1M). The position peaked in Q3 2024 at 368,665 shares, worth US$14.7M. Across 13 filings, Nan Fung Group Holdings Ltd increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 27,049 shares valued at US$1.1M. Notable position changes include a 93% trim in Q3 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 368.67K $12.08M New
Q4 2023 368.67K $11.91M Hold
Q1 2024 368.67K $12.38M Hold
Q2 2024 368.67K $11.12M Hold
Q3 2024 368.67K $14.75M Hold
Q4 2024 368.67K $12.69M Hold
Q1 2025 368.67K $12.24M Hold
Q2 2025 368.67K $11.65M Hold
Q3 2025 27.05K $745.47K Reduce
Q4 2025 27.05K $1.01M Hold
Q1 2026 27.05K $757.64K Hold
Q2 2026 27.05K $984.85K Hold
Q3 2026 27.05K $1.06M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRMY and 13F data

HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 38 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRMY

All HRMY fund holders →

FAQ

How long has Nan Fung Group Holdings Ltd held HRMY?

Nan Fung Group Holdings Ltd has disclosed HRMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nan Fung Group Holdings Ltd's current position in HRMY?

As of Q3 2026, Nan Fung Group Holdings Ltd holds 27.05K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $1.06M, representing 0.72% of its reported portfolio and ranking #21.

Has Nan Fung Group Holdings Ltd been buying or selling HRMY?

In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in HRMY. The position peaked in Q3 2024 at 368.67K shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.